Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles

Stroke. 2006 Feb;37(2):495-500. doi: 10.1161/01.STR.0000199033.06678.c3. Epub 2005 Dec 22.

Abstract

Background and purpose: Our goal was to determine whether NAD(P)H oxidase is involved in impaired endothelial nitric oxide synthase (eNOS)-dependent reactivity of cerebral arterioles during chronic alcohol consumption.

Methods: Sprague-Dawley rats were fed with an alcohol diet for 2 to 3 months. We determined the effects of acute and chronic treatment with an NAD(P)H oxidase inhibitor, apocynin, on responses of pial arterioles to eNOS-dependent agonists (acetylcholine and ADP) and an eNOS-independent agonist (nitroglycerin). Expression of NAD(P)H oxidase in pial arterioles was measured with the use of real-time polymerase chain reaction and Western blot analysis, and superoxide production was measured with the use of lucigenin-enhanced chemiluminescence.

Results: Vasodilation in response to acetylcholine and ADP, but not nitroglycerin, was significantly less in alcohol-fed rats. Treatment with apocynin did not alter vasodilation in non-alcohol-fed rats but significantly improved impaired vasodilation in alcohol-fed rats. In addition, an upregulation of p47phox in pial arterioles was found in alcohol-fed rats. Furthermore, alcohol consumption increased superoxide production under basal conditions and in the presence of ADP and NAD(P)H.

Conclusions: Our findings suggest that NAD(P)H oxidase plays a role in chronic alcohol consumption-induced impairment of eNOS-dependent dilation of cerebral arterioles.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology
  • Acetylcholine / pharmacology
  • Acridines / pharmacology
  • Adenosine Diphosphate / chemistry
  • Alcohol Drinking
  • Alcohols / pharmacology*
  • Animals
  • Blotting, Western
  • Body Weight
  • Central Nervous System Depressants / pharmacology
  • Cerebral Arteries / pathology*
  • Cerebrovascular Circulation
  • Dilatation, Pathologic / pathology
  • Enzyme Inhibitors / pharmacology
  • Luminescence
  • Male
  • Models, Statistical
  • NADPH Oxidases / metabolism
  • NADPH Oxidases / physiology*
  • Nitric Oxide Synthase Type III / metabolism*
  • Nitroglycerin / pharmacology
  • Phosphoproteins / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stroke / pathology
  • Superoxides / metabolism
  • Time Factors
  • Up-Regulation
  • Vasodilation
  • Vasodilator Agents / pharmacology

Substances

  • Acetophenones
  • Acridines
  • Alcohols
  • Central Nervous System Depressants
  • Enzyme Inhibitors
  • Phosphoproteins
  • Vasodilator Agents
  • Superoxides
  • 10,10'-dimethyl-9,9'-biacridinium
  • Adenosine Diphosphate
  • acetovanillone
  • Nitric Oxide Synthase Type III
  • NADPH Oxidases
  • neutrophil cytosolic factor 1
  • Nitroglycerin
  • Acetylcholine